Improvements in liver enzymes such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST) as well as fibrosis markers such as the NAFLD fibrosis score and hepatic steatosis index, have been reported. This evidence concerns the gene GPT and fatty liver disease.